CG Oncology (CGON) Stock: Buy, Sell, or Hold?
CGON - CG Oncology, Inc. Common stock
$62.24
0.31 (0.50%)
▲
5d:
+0.65%
30d:
-19.94%
90d:
-12.49%
BUY
HIGH Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 13, 2026
21d
Get Alerted When CGON Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CGON shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: CGON shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: CGON is currently trading at $62.24, which is considered slightly low relative to its 30-day fair value range of $62.23 to $73.33.
Technical Outlook: Technically, CGON is in a uptrend. Immediate support is located at $59.22, while resistance sits at $65.18.
Market Sentiment: CGON scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $91.08 (+46.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CGON is in a uptrend. Immediate support is located at $59.22, while resistance sits at $65.18.
Market Sentiment: CGON scores 96/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $91.08 (+46.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$62.23 -
$73.33
Company Quality Score
73/100
(BUY)
Options IV Signal
51th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 51th percentile)
- BULLISH: Strong technical setup (96/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.3% below Wall St target ($91.08)
- BULLISH: Bottoming setup score 96/100 — corrected, stabilizing, and turning up
Trading Range Analysis
30-Day Trading Range
$62.23 -
$73.33
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$9.35
(15.0%)
Support & Resistance Levels
Support Level
$59.22
Resistance Level
$65.18
Current Trend
Uptrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-20.60
Wall Street Target
$91.08
(+46.3%)
Revenue Growth (YoY)
1982.7%
Share & Embed Analysis
Last updated: October 22, 2026 5:27 AM ET
Data refreshes hourly during market hours. Next update: 6:27 AM
Data refreshes hourly during market hours. Next update: 6:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CGON showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$197 | 60 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$109 | 66 BUY |
|
MDGL
Madrigal Pharmaceuticals… |
STRONG BUY
19 analysts |
$686 | 59 HOLD |
|
IMNM
Immunome Inc |
STRONG BUY
16 analysts |
$35 | 63 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
23 analysts |
$86 | 64 BUY |
